Women in Science
PANEL DISCUSSION: The Time is NOW: Creating Meaningful Change for Women in The Workplace
There is increasing evidence that women in executive leadership positions and on corporate boards
do have a positive impact on innovation and on company’s financial performance. Studies have concluded that a diverse C-Suite and board of directors translates into higher margins, improved profits, and increased total return to shareholders.
In addition, and often unappreciated, diversity will help a company attract and retain the talent a company needs for the future, so they can continue to get novel products to market. Despite this, there is still a shortage of women in executive leadership
positions and board seats.
Our industry has a social responsibility to ramp up advocacy for the creation of a level playing field and to move businesses in the right direction towards gender equality.
This session will life science senior leaders who have the influence to adopt change in their respective companies. Throughout the event, we will foster collaboration, encourage deeper discussions, and provide meaningful solutions for companies seeking
to remain competitive. Robin Toft’s session is designed to engage, inform and connect participants on how together WE CAN advance female career progression and create inclusive working environments which recognize and champion the achievements
of all leaders.
- The global talent crisis is real, the landscape is fiercely competitive, and female candidates are in high demand.
- Playbook for Success - how companies can attract and retain top talent in today’s competitive environment.
- Practical Advice and Guidance for women to rapidly position themselves for the C-suite and boardroom.
Robin Toft is the founder and CEO of Toft Group Executive Search, where she combines a deep inside knowledge of
the life science industry with a passion for building game-changing management teams. Robin has placed more than 500 executives at innovation-led companies in biotechnology, pharmaceuticals, diagnostics, medical devices, life science tools and digital
health. A champion of diverse executive teams, Robin has built a reputation for recruiting women and minorities into top roles and helping the life science industry overcome unconscious bias in hiring. Prior to founding Toft Group in 2010, Robin served
20+ years as a biotech executive. In 2019, Robin authored her first book, “WE CAN: The Executive Woman’s Guide to Career Advancement,” available on Amazon. WE CAN offers practical insight, wisdom and encouragement for women
to realize the career of their dreams. It is recognized within the list of 100 Best CEO Books of All Time by BookAuthority. Robin serves on multiple non-profit boards, is an inaugural member of the Susan G. Komen San Diego Advisory Council, was awarded
Woman of the Year in San Diego in 2017, and a finalist in Ernst & Young’s prestigious Entrepreneur of the Year awards in 2018 and 2019. She has been honored as a finalist for San Diego Business Journal’s “Women Who Mean Business”
and “Most Admired CEO” awards in multiple years.
Robin will be signing copies of her book, “WE CAN: The Executive Woman’s Guide to Career Advancement” at the Molecular
Medicine Tri-Conference. Stay tuned for more details!